Jindawei: Subsidiary Obtains Utility Model Patent for "Monosaccharide Precrystallization Device"

Jindawei announced that the company and its subsidiary Inner Mongolia Jinda Wei Pharmaceutical Co., Ltd. recently received a utility model patent certificate issued by the State Intellectual Property Office. The patent is named "a monosaccharide pre-crystallization device, a monosaccharide crystallization device", with patent number ZL202423231299.X, application date of December 26, 2024, and patent holders including Inner Mongolia Jinda Wei Pharmaceutical Co., Ltd. and Jinda Wei. The term of the patent is ten years. The patent authorization announcement date is January 16, 2026. Although it will not have a significant impact on the company's production and operation, it is beneficial for technological innovation and enhancing core competitiveness.